Literature DB >> 19601578

X-ray crystal structure of human heme oxygenase-1 with (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4[((5-trifluoromethylpyridin-2-yl)thio)methyl]-1,3-dioxolane: a novel, inducible binding mode.

Mona N Rahman1, Jason Z Vlahakis, Dragic Vukomanovic, Walter A Szarek, Kanji Nakatsu, Zongchao Jia.   

Abstract

The crystal structure of human heme oxygenase-1 (HO-1) in complex with (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4[((5-trifluoromethylpyridin-2-yl)thio)methyl]-1,3-dioxolane (4) reveals a novel, inducible binding mode. Inhibitor 4 coordinates the heme iron, with its chlorophenyl group bound in a distal hydrophobic pocket, as seen in previous structures. However, accommodation of the 5-trifluoromethylpyridin-2-yl group requires a significant shift in the proximal helix, inducing the formation of a hydrophobic pocket. This is the first example of an induced binding pocket observed in HO-1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601578     DOI: 10.1021/jm900434f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds.

Authors:  Mona N Rahman; Dragic Vukomanovic; Jason Z Vlahakis; Walter A Szarek; Kanji Nakatsu; Zongchao Jia
Journal:  J R Soc Interface       Date:  2012-11-08       Impact factor: 4.118

2.  East to West not North-West: Structure-Based Mechanistic Resolution of 8-Hydroxyl Replacement and Resulting Effects on the Activities of Imidazole-Based Heme Oxygenase-1 Inhibitors.

Authors:  Felix O Okunlola; Opeyemi S Soremekun; Fisayo A Olotu; Mahmoud E S Soliman
Journal:  Protein J       Date:  2021-03-01       Impact factor: 2.371

Review 3.  Novel lead structures and activation mechanisms for CO-releasing molecules (CORMs).

Authors:  U Schatzschneider
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

4.  A novel, "double-clamp" binding mode for human heme oxygenase-1 inhibition.

Authors:  Mona N Rahman; Jason Z Vlahakis; Dragic Vukomanovic; Wallace Lee; Walter A Szarek; Kanji Nakatsu; Zongchao Jia
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

5.  Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent In Vitro Antiproliferative Activity.

Authors:  Antonino N Fallica; Valeria Sorrenti; Agata G D'Amico; Loredana Salerno; Giuseppe Romeo; Sebastiano Intagliata; Valeria Consoli; Giuseppe Floresta; Antonio Rescifina; Velia D'Agata; Luca Vanella; Valeria Pittalà
Journal:  J Med Chem       Date:  2021-09-02       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.